193 related articles for article (PubMed ID: 26821710)
21. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome.
Belichenko NP; Belichenko PV; Li HH; Mobley WC; Francke U
J Comp Neurol; 2008 May; 508(1):184-95. PubMed ID: 18306326
[TBL] [Abstract][Full Text] [Related]
23. MeCP2 mutation results in compartment-specific reductions in dendritic branching and spine density in layer 5 motor cortical neurons of YFP-H mice.
Stuss DP; Boyd JD; Levin DB; Delaney KR
PLoS One; 2012; 7(3):e31896. PubMed ID: 22412847
[TBL] [Abstract][Full Text] [Related]
24. A role for glia in the progression of Rett's syndrome.
Lioy DT; Garg SK; Monaghan CE; Raber J; Foust KD; Kaspar BK; Hirrlinger PG; Kirchhoff F; Bissonnette JM; Ballas N; Mandel G
Nature; 2011 Jun; 475(7357):497-500. PubMed ID: 21716289
[TBL] [Abstract][Full Text] [Related]
25. Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.
Bedogni F; Cobolli Gigli C; Pozzi D; Rossi RL; Scaramuzza L; Rossetti G; Pagani M; Kilstrup-Nielsen C; Matteoli M; Landsberger N
Cereb Cortex; 2016 Jun; 26(6):2517-2529. PubMed ID: 25979088
[TBL] [Abstract][Full Text] [Related]
26. An optogenetic mouse model of rett syndrome targeting on catecholaminergic neurons.
Zhang S; Johnson CM; Cui N; Xing H; Zhong W; Wu Y; Jiang C
J Neurosci Res; 2016 Oct; 94(10):896-906. PubMed ID: 27317352
[TBL] [Abstract][Full Text] [Related]
27. Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders.
Bach S; Ryan NM; Guasoni P; Corvin AP; El-Nemr RA; Khan D; Sanfeliu A; Tropea D
Sci Rep; 2020 Dec; 10(1):22255. PubMed ID: 33335218
[TBL] [Abstract][Full Text] [Related]
28. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons.
Yazdani M; Deogracias R; Guy J; Poot RA; Bird A; Barde YA
Stem Cells; 2012 Oct; 30(10):2128-39. PubMed ID: 22865604
[TBL] [Abstract][Full Text] [Related]
29. MeCP2 deficiency is associated with impaired microtubule stability.
Delépine C; Nectoux J; Bahi-Buisson N; Chelly J; Bienvenu T
FEBS Lett; 2013 Jan; 587(2):245-53. PubMed ID: 23238081
[TBL] [Abstract][Full Text] [Related]
30. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
31. MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons.
Kishi N; Macklis JD
Exp Neurol; 2010 Mar; 222(1):51-8. PubMed ID: 20025874
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation.
Sun J; Osenberg S; Irwin A; Ma LH; Lee N; Xiang Y; Li F; Wan YW; Park IH; Maletic-Savatic M; Ballas N
Cell Rep; 2023 Jan; 42(1):111942. PubMed ID: 36640327
[TBL] [Abstract][Full Text] [Related]
33. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
34. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons.
Smrt RD; Eaves-Egenes J; Barkho BZ; Santistevan NJ; Zhao C; Aimone JB; Gage FH; Zhao X
Neurobiol Dis; 2007 Jul; 27(1):77-89. PubMed ID: 17532643
[TBL] [Abstract][Full Text] [Related]
35. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress.
Zhao D; Mokhtari R; Pedrosa E; Birnbaum R; Zheng D; Lachman HM
Mol Autism; 2017; 8():17. PubMed ID: 28367307
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic exposure to low dose THIP on brainstem neuronal excitability in mouse models of Rett syndrome: Evidence from symptomatic females.
Zhong W; Johnson CM; Cui N; Xing H; Wu Y; Jiang C
Neuropharmacology; 2017 Apr; 116():288-299. PubMed ID: 28069353
[TBL] [Abstract][Full Text] [Related]
38. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
39. A segment of the Mecp2 promoter is sufficient to drive expression in neurons.
Adachi M; Keefer EW; Jones FS
Hum Mol Genet; 2005 Dec; 14(23):3709-22. PubMed ID: 16251199
[TBL] [Abstract][Full Text] [Related]
40. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.
Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW
PLoS One; 2007 Jan; 2(1):e157. PubMed ID: 17237885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
